Results 11 to 20 of about 6,696 (158)

Emetine is not ipecac: considerations for its use as treatment for SARS-CoV2 [PDF]

open access: yesPharmaceuticals, 2020
Emetine is a potent antiviral that acts on many viruses in the low-nM range, with several studies in animals and humans demonstrating antiviral activity. Historically, emetine was used to treat patients with Spanish influenza, in the last stages of the
Martin Bleasel (14731945)   +1 more
core   +4 more sources

Emetine, ipecac, ipecac alkaloids and analogues as potential antiviral agents for coronaviruses

open access: yesPharmaceuticals, 2020
The COVID-19 coronavirus is currently spreading around the globe with limited treatment options available. This article presents the rationale for potentially using old drugs (emetine, other ipecac alkaloids or analogues) that have been used to treat ...
Martin Bleasel (14731945)   +1 more
core   +3 more sources

Efficacy and Mechanism of Action of Low Dose Emetine against Human Cytomegalovirus. [PDF]

open access: yesPLoS Pathogens, 2016
Infection with human cytomegalovirus (HCMV) is a threat for pregnant women and immunocompromised hosts. Although limited drugs are available, development of new agents against HCMV is desired. Through screening of the LOPAC library, we identified emetine
Xin Hu (38924)   +29 more
core   +2 more sources

Emetine Di-HCl Attenuates Type 1 Diabetes Mellitus in Mice

open access: yesMolecular Medicine, 2016
Type 1 diabetes mellitus (T1D) is a chronic autoimmune disease characterized by β cell destruction, insulin deficiency and hyperglycemia. Activated macrophages and autoimmune T cells play a crucial role in the pathogenesis of hyperglycemia in NOD murine ...
Harold A Silverman   +20 more
core   +2 more sources

Cryo-EM structure of the Plasmodium falciparum 80S ribosome bound to the anti-protozoan drug emetine [PDF]

open access: yeseLife, 2014
Malaria inflicts an enormous burden on global human health. The emergence of parasite resistance to front-line drugs has prompted a renewed focus on the repositioning of clinically approved drugs as potential anti-malarial therapies.
Hanssen, E   +8 more
core   +3 more sources

Therapeutic potential of natural alkaloid emetine against emerging COVID-19 and future viral pandemics

open access: yesEuropean Journal of Medicinal Chemistry Reports
The outbreak of COVID-19 pandemic caused by the infection of SARS-CoV-2, has become a global crisis, threatening public health and disrupting global economy.
Subhajit Dinda   +5 more
core   +2 more sources

Emetine blocks DNA replication via proteosynthesis inhibition not by targeting Okazaki fragments

open access: yesLife Science Alliance, 2022
This study clarifies the long-standing misuse of emetine as a lagging strand synthesis-specific inhibitor. Emetine blocks the synthesis of both DNA strands by the inhibition of protein biosynthesis.
David Lukac   +2 more
doaj   +1 more source

In vitro screening of effectiveness and antiproliferative effects of potential DDIT4 inhibitors for breast cancer cell lines

open access: yesСибирский онкологический журнал, 2022
Objective: screening of previously selected DDIT4 inhibitors by their ability to suppress basal and glucocorticoid-induced expression of this gene in breast cancer (BC) cells, as well as evaluation of antiproliferative and cytotoxic effects of the ...
E. M. Zhidkova   +9 more
doaj   +1 more source

Impairment of FOS mRNA stabilization following translation arrest in granulocytes from myelodysplastic syndrome patients. [PDF]

open access: yesPLoS ONE, 2013
Although quantitative and qualitative granulocyte defects have been described in myelodysplastic syndromes (MDS), the underlying molecular basis of granulocyte dysfunction in MDS is largely unknown.
Xiaomin Feng   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy